Total Funding
93
81
Total FundingPost-IPO Equity raised
Growth Score
-5 pts
Heat Score
7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
20778
Ainos is a medical technology company that provides low-dose interferon drug solutions, AI-powered medical devices and preventive medicine.
About the Company
Ainos develops medical technologies that combine artificial intelligence with diagnostics and therapeutics. The company's services include AI-powered sensing systems that convert chemical signals into digital data for analysis, enabling applications in healthcare, robotics, and industrial environments. Ainos also provides point-of-care testing
solutions designed for rapid and non-invasive diagnostics, including devices for infectious diseases and women’s health. In addition, it develops low-dose oral interferon therapeutics and explores synthetic RNA approaches for disease treatment and prevention, supported by clinical research and data-driven methodologies.
